<DOC>
	<DOCNO>NCT01911455</DOCNO>
	<brief_summary>In research study want understand effectiveness drug treatment , acamprosate , interfere symptom ( i.e. , inattention/hyperactivity , social impairment ) associate Fragile X Syndrome ( FXS ) .</brief_summary>
	<brief_title>Study Acamprosate Fragile x Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Acamprosate</mesh_term>
	<criteria>Diagnostic confirmation full mutation FXS Age â‰¥5 year &lt; 23 year General good health determine physical exam , medical history laboratory work . Use two psychotropic medication ( medication affect behavior ) . Unstable dose psychotropic medication ( medication affect behavior ) Problems kidney function Unstable seizure disorder Change anticonvulsant drug dose 60 day prior study entry Prior adequate treatment trial acamprosate determine study doctor Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fragile X Syndrome</keyword>
</DOC>